Compare PEN & GMED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PEN | GMED |
|---|---|---|
| Founded | 2004 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.9B | 12.9B |
| IPO Year | 2015 | 2012 |
| Metric | PEN | GMED |
|---|---|---|
| Price | $331.86 | $94.42 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 17 | 14 |
| Target Price | ★ $357.33 | $100.42 |
| AVG Volume (30 Days) | 512.7K | ★ 998.3K |
| Earning Date | 04-30-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 1155.56 | 422.67 |
| EPS | ★ 4.52 | 3.92 |
| Revenue | $1,403,665,000.00 | ★ $2,938,931,000.00 |
| Revenue This Year | $14.34 | $11.13 |
| Revenue Next Year | $13.71 | $6.28 |
| P/E Ratio | $72.54 | ★ $23.95 |
| Revenue Growth | ★ 17.50 | 16.65 |
| 52 Week Low | $221.26 | $51.79 |
| 52 Week High | $362.41 | $101.40 |
| Indicator | PEN | GMED |
|---|---|---|
| Relative Strength Index (RSI) | 49.46 | 58.77 |
| Support Level | $326.58 | $85.01 |
| Resistance Level | $336.01 | $97.87 |
| Average True Range (ATR) | 2.27 | 3.01 |
| MACD | 0.23 | 0.52 |
| Stochastic Oscillator | 58.27 | 76.32 |
Penumbra Inc is a thrombectomy company focused on developing technologies for challenging medical conditions such as ischemic stroke, venous thromboembolism (including pulmonary embolism), and acute limb ischemia. Its portfolio includes Computer-Assisted Vacuum Thrombectomy (CAVT), which is designed to remove blood clots throughout the body. The company offers products such as the Artemis Neuro Evacuation Device (used for surgical removal of fluid and tissue from the ventricles and cerebrum), Indigo System, Penumbra System Reperfusion Catheter, LANTERN Delivery Microcatheter, Penumbra Smart Coil, and ACE Reperfusion Catheters, among others. The company generates maximum revenue from the sale of its products in the United States, followed by international markets.
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.